DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers

Identification of early changes in Dopamine-Transporter (DaT) SPECT imaging expected in the prodromal phase of Parkinson’s disease (PD), are usually overlooked. Carriers of the G2019S LRRK2 mutation are known to be at high risk for developing PD, compared to non-carriers. In this work we aimed to st...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Artzi, Moran, Even-Sapir, Einat, Lerman Shacham, Hedva, Thaler, Avner, Urterger, Avi Orr, Bressman, Susan, Marder, Karen, Hendler, Talma, Giladi, Nir, Ben Bashat, Dafna, Mirelman, Anat
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5391020/
https://ncbi.nlm.nih.gov/pubmed/28406934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175424
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak